Business Description
GenMont Biotech Inc
NAICS : 541711
SIC : 8731
ISIN : TW0003164000
Description
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.87 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.77 | |||||
| Interest Coverage | 22.36 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 5.3 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.2 | |||||
| 3-Year EBITDA Growth Rate | -1 | |||||
| 3-Year EPS without NRI Growth Rate | -17.3 | |||||
| 3-Year FCF Growth Rate | 64 | |||||
| 3-Year Book Growth Rate | -0.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.73 | |||||
| 9-Day RSI | 66.24 | |||||
| 14-Day RSI | 65.16 | |||||
| 6-1 Month Momentum % | -7.14 | |||||
| 12-1 Month Momentum % | -16.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | |||||
| Quick Ratio | 2.31 | |||||
| Cash Ratio | 2.07 | |||||
| Days Inventory | 238.33 | |||||
| Days Sales Outstanding | 42.69 | |||||
| Days Payable | 23.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.87 | |||||
| Dividend Payout Ratio | 1.07 | |||||
| 3-Year Dividend Growth Rate | -4.7 | |||||
| Forward Dividend Yield % | 2.87 | |||||
| 5-Year Yield-on-Cost % | 2.86 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 1.23 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.81 | |||||
| Operating Margin % | 9.26 | |||||
| Net Margin % | 16.77 | |||||
| FCF Margin % | 2.57 | |||||
| ROE % | 4.54 | |||||
| ROA % | 3.56 | |||||
| ROIC % | 2.1 | |||||
| ROC (Joel Greenblatt) % | 5.95 | |||||
| ROCE % | 4.27 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 35.88 | |||||
| PE Ratio without NRI | 37.19 | |||||
| PS Ratio | 6.1 | |||||
| PB Ratio | 1.6 | |||||
| Price-to-Tangible-Book | 1.6 | |||||
| Price-to-Free-Cash-Flow | 180.74 | |||||
| Price-to-Operating-Cash-Flow | 28.47 | |||||
| EV-to-EBIT | 28.4 | |||||
| EV-to-EBITDA | 13.88 | |||||
| EV-to-Revenue | 5.15 | |||||
| EV-to-FCF | 197.95 | |||||
| Price-to-Projected-FCF | 6.7 | |||||
| Price-to-Median-PS-Value | 1.08 | |||||
| Price-to-Graham-Number | 1.63 | |||||
| Price-to-Net-Current-Asset-Value | 17.18 | |||||
| Earnings Yield (Greenblatt) % | 3.52 | |||||
| FCF Yield % | 0.43 | |||||
| Forward Rate of Return (Yacktman) % | -1.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GenMont Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 354.809 | ||
| EPS (TTM) (NT$) | 0.68 | ||
| Beta | 0.19 | ||
| Volatility % | 13.09 | ||
| 14-Day RSI | 65.16 | ||
| 14-Day ATR (NT$) | 0.478664 | ||
| 20-Day SMA (NT$) | 23.6475 | ||
| 12-1 Month Momentum % | -16.76 | ||
| 52-Week Range (NT$) | 21.4 - 26.5 | ||
| Shares Outstanding (Mil) | 86.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GenMont Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GenMont Biotech Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
GenMont Biotech Inc Frequently Asked Questions
What is GenMont Biotech Inc(TPE:3164)'s stock price today?
The current price of TPE:3164 is NT$24.40. The 52 week high of TPE:3164 is NT$26.50 and 52 week low is NT$21.40.
When is next earnings date of GenMont Biotech Inc(TPE:3164)?
The next earnings date of GenMont Biotech Inc(TPE:3164) is .
Does GenMont Biotech Inc(TPE:3164) pay dividends? If so, how much?
The Dividend Yield %  of GenMont Biotech Inc(TPE:3164) is 2.87% (As of Today), Highest Dividend Payout Ratio of GenMont Biotech Inc(TPE:3164) was 2.37. The lowest was 0.53. And the median was 1.71. The  Forward Dividend Yield % of GenMont Biotech Inc(TPE:3164) is 2.87%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers